Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an experimental drug, GEN1106, for people with solid tumors that have not responded to standard treatments. It aims to see if the drug can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must have progressed or not responded to all standard treatments (including chemo, immunotherapy, or targeted therapy).
- You need to have at least one measurable tumor, meaning it can be seen on scans and measured.
- You should be able to care for yourself and be up and about (a performance status of 0 or 1).
- For the first part of the study, any solid tumor type is allowed. For later parts, you must have metastatic bladder cancer.
- You cannot have received a type of drug called a topoisomerase 1 inhibitor-based antibody-drug conjugate before.
- You need to be at least 4 weeks past any previous cancer treatment or 5 drug half-lives, whichever is shorter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, PF-08046876, for people with advanced cancers of the bladder, lung, head and neck, esophagus, or pancreas. It aims to see if the drug is safe and works against these cancers.
This study tests an experimental drug called BA1106 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe, tolerable, and whether it can help shrink tumors.
This trial tests an experimental drug called GEN1079 for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if it's safe and if it helps shrink tumors.
This trial tests a new experimental drug called GEN1119 for people with solid tumors that have stopped responding to standard treatments. It's an early-phase study to see if the drug is safe and how well it works.
This trial tests a new drug (SI-B036) for people with advanced urological tumors or other solid tumors that have spread. The goal is to see if the drug is safe and effective, and it might help shrink tumors or slow their growth.
This trial tests two new drugs, P1101 and P1801, in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and effective.
Hear when a new Urothelial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.